HOME >> BIOLOGY >> NEWS
Designing vaccines by computer

Having vaccines developed by computer may sound unnerving but the increasing role of computer modelling in the development of new vaccines could bring new products onto the market quicker, benefiting patients and saving pharmaceutical companies millions of pounds.

Researchers using informatics and computer modelling can help scientists to uncover and harness the hidden patterns in the wealth of DNA and protein sequences that modern bioscience generates and cut the number of compounds drug companies need to test when searching for new vaccines.

Researchers funded by the Biotechnology and Biological Sciences Research Council (BBSRC) and working at the Edward Jenner Institute for Vaccine Research are using a very simple concept to help speed up the development of vaccines. They are studying fragments of 'foreign' proteins that have been shown by experiments to effectively trigger a response by the immune system. They look for common patterns in their sequences or structures and use the information to create a theoretical model of what is needed for one of these fragments to trigger an immune response. They can then employ computers to search for similar sequences in the thousands of sequences now available. When the search finds something promising it can be experimentally tested to see if it will trigger a response.

Dr Darren Flower, an international leader in this work, said, "A crucial feature of this search strategy is that we don't have to know what a foreign protein actually does in order to identify it as having fragments that that could make good vaccines. This approach has the potential to significantly reduce the number of proteins that we need to experimentally test to develop new vaccines to protect both humans and economically important livestock."

Professor Nigel Brown, BBSRC Director of Science and Technology, said, "Predictive biology, such as this work, has the potential to bring vaccines and medicines to patients fast
'"/>

Contact: Matt Goode
matt.goode@bbsrc.ac.uk
44-179-341-3299
Biotechnology and Biological Sciences Research Council
12-Apr-2005


Page: 1 2

Related biology news :

1. First genome-wide study of infectious disease opens new avenues for HIV treatment, vaccines
2. Smallpox outbreak: How long would it take for vaccines to protect people? Would it work?
3. Human trial results show excellent safety data, from Geovaxs DNA/MVA AIDS vaccines
4. Botulism study could lead to new vaccines and treatments to counter bioterrorist attacks
5. Painkillers may threaten power of vaccines
6. Interdisciplinary grant to Yale: Creating nanodevices for delivery of vaccines
7. Protecting virus offers instant flu protection and converts flu infections into their own vaccines
8. Handling HPV vaccines and screening: The views of 100 authors
9. Promising preclinical results with live attenuated H5N1 vaccines
10. Producing flu vaccines will be faster and cheaper, thanks to MSU technology
11. Experts urge industry and international donors to prepare pneumococcal vaccines

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Designing vaccines computer

(Date:5/18/2013)... Research presented today at Digestive Disease Week (DDW) ... about the impact of coffee on autoimmune disease and ... consumption recently has been associated with reduced risk of ... more cups of java each month also correlate with ... at the Mayo Clinic, Rochester, MN, linked coffee consumption ...
(Date:5/18/2013)... An increasing number of U.S. children are ... according to research presented at Digestive Disease Week ... researchers at the Cleveland Clinic Children,s Hospital found ... exhaled breath compared to their lean counterparts. The ... that can be correlated to potential complications associated ...
(Date:5/17/2013)... insects provide the white noise of the South, but the ... the Southern air hangs heavy from the humidity and the ... than 140 species of frogs, toads and salamanders, is the ... ponds and swamps are the auditorium for their symphonic choruses, ... Monitoring Initiative, or ARMI, have front-row seats. , ...
Breaking Biology News(10 mins):Coffee consumption associated with reduced risk of autoimmune liver disease 2New research identifies risks, interventions for children's GI health 2New research identifies risks, interventions for children's GI health 3Front-row seats to climate change 2Front-row seats to climate change 3Front-row seats to climate change 4
(Date:5/21/2013)... TX (PRWEB) May 21, 2013 Smarter ... outdoor security solutions, today announced that Genzyme, a Sanofi ... units of Door Detective® CL for a multi-use facility ... installed in four other Genzyme buildings, this latest order ... with the tailgate detection device improving doorway ...
(Date:5/21/2013)... 2013  MacroGenics, Inc. today announced that an ... an Fc-modified chimeric monoclonal antibody (MAb), in patients ... will be presented at the 2013 Annual Meeting ... the Developmental Therapeutics - Immunotherapy Oral Abstract Session ... PM.  The presentation will describe the results of ...
(Date:5/21/2013)... May 21, 2013 NANONEX CORPORATION, ... solutions , today announced the successful delivery and ... system, the NX-M200B, to a major Japanese manufacturing ... a fully-automated, production-ready, advanced nanoimprint lithography tool that ... wafer and substrate sizes and types. Based on ...
(Date:5/21/2013)... 2013 PathoGenetix, Inc., a commercial-stage developer ... announced today that it has successfully identified and strain ... obtained from the Centers for Disease Control and Prevention ... The findings are detailed in a poster ... for Microbiology in Denver on Monday. , The 250 ...
Breaking Biology Technology:Door Security at Genzyme, a Sanofi Company, Enhanced with Door Detective from Smarter Security 2Door Security at Genzyme, a Sanofi Company, Enhanced with Door Detective from Smarter Security 3MacroGenics Announces Margetuximab (MGAH22) Phase 1 Data Presentation at ASCO; Initiates Phase 2 Clinical Study to Evaluate Activity of Margetuximab in Patients with Metastatic Breast Cancer 2MacroGenics Announces Margetuximab (MGAH22) Phase 1 Data Presentation at ASCO; Initiates Phase 2 Clinical Study to Evaluate Activity of Margetuximab in Patients with Metastatic Breast Cancer 3Nanonex Announces the Shipment and Installation of an Innovative Nanoimprint Lithography System for Fully Automated Manufacturing 2New Genotyping System Identifies Pathogenic E. coli Outbreak Strains 2New Genotyping System Identifies Pathogenic E. coli Outbreak Strains 3
Cached News: